Serum cystatin C as a marker of the renal function

REFERENCES

• Perrone RD, Madias NE, Levey AS. Serum creati-nine as an index of renal function: new insights into old concepts. Clin Chem 1992; 38: 1933–53.
   Google Scholar
• Swan SK. The search continues-an ideal marker of GFR. Clin Chem 1997; 43: 913–4.
   PubMed Web of Science ®Google Scholar
• Olafsson I. The human cystatin C gene promoter: functional analysis and identification of hetero- geneous mRNA. Scand J Clin Lab Invest 1995; 55: 597–607.
   PubMed Web of Science ®Google Scholar
• Grubb A, Lififberg H. Human 7-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis. Proc Natl Acad Sci USA 1982; 79: 3024–7.
   PubMed Web of Science ®Google Scholar
• Abrahamson M, Olafsson I, Palsdottir A, Ulvsbäck M, Lundwall A, Jensson 0, et al. Struc-ture and expression of the human cystatin C gene. Biochem J 1990; 268: 287–94.
   Google Scholar
• Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol 1992; 38 Supp. 1: 20–7.
   Google Scholar
• Tenstad 0, Roald AB, Grubb A, Aukland K. Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest 1996; 56: 409–14.
   PubMed Web of Science ®Google Scholar
• Nilsson-Ehle P, Grubb A. New markers for the determination of GFR: iohexol clearance and cystatin C serum concentration. Kidney Int 1994; 46 Supp. 47: 17–9.
   Google Scholar
• Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindström V, et al. Serum cystatin C, determined by a rapid, auto-mated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 1994; 40: 1921–6.
   Google Scholar
• Pergande M, Jung K. Sandwich enzyme immu-noassay of cystatin C in serum with commercially available antibodies. Clin Chem 1993; 39: 1885–90.
   PubMed Web of Science ®Google Scholar
• Finney H, Newman DJ, Gruber W, Merle P, Price CP. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem 1997; 43: 1016–22.
   Google Scholar
• Filler G, Witt I, Priem F, Ehrich JHH, Jung K. Are cystatin C and 132-microglobulin better markers than serum creatinine for prediction of a normal glomerular filtration rate in pediatric subjects? Clin Chem 1997; 43: 1077–8.
   Google Scholar
• Lififberg H, Grubb AO. Quantitation of 7-trace in human biological fluids: indications for production in the central nervous system. Scand J Clin Lab Invest 1979; 39: 619–26.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, et al. Serum cystatin C mea-sured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995; 47: 312–8.
   PubMed Web of Science ®Google Scholar
• Collé A, Tavera C, Prévot D, Leung-Tack J, Thomas Y, Manuel Y, etal. Cystatin C levels in sera of patients with human immunodeficiency virus infection. J Immunoassay 1992; 13: 47–60.
   Google Scholar
• Ishiguro H, Ohkubo I, Mizokami M, Titani K, Sasaki M. The use of monoclonal antibodies to define levels of cystatin C in normal human serum. Hybridoma 1989; 8: 303–13.
   Google Scholar
• Olafsson I, Löfberg H, Abrahamson M, Grubb A. Production, characterization and use of mono-clonal antibodies against the major extracellular human cysteine proteinase inhibitors cystatin C and kininogen. Scand J Clin Lab Invest 1988; 48: 573–82.
   PubMed Web of Science ®Google Scholar
• Christensen AB, Groth S. Determination of 99mTc- DTPA clearance by a single plasma sample method. Clin Physiol 1986; 6: 579–88.
   PubMedGoogle Scholar
• Zweig MH, Campbell G. Receiver-operating charac-teristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561–77.
   PubMed Web of Science ®Google Scholar
• Weber JA, van Zanten AP. Interferences in current methods for measurements of creatinine. Clin Chem 1991; 37: 695–700.
   PubMed Web of Science ®Google Scholar
• Shemesh 0, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985; 28: 830–8.
   PubMed Web of Science ®Google Scholar
• Mitch WE, Walser M. Nutritional therapy for the ure-mic patient. In: Brenner BM, editor. The kidney, 5th ed. Philadelphia: W. B. Saunders, 1996: 2382–423.
   Google Scholar
• Giovanetti S, Barsotti G. In defense of creatinine clearance. Nephron 1991; 59: 11–4.
   PubMed Web of Science ®Google Scholar
• Narayanan S, Appleton HD. Creatinine: a review. Clin Chem 1980; 26: 1119–26.
   PubMed Web of Science ®Google Scholar
• Sigman EM, Elwood C, Reagan ME, Morris AM, Catanzaro A. The renal clearance of 1131 labelled sodium iothalamate in man. Invest Urol 1965; 2: 432–8.
   Google Scholar
• Dubovsky EV, Russell CD. Quantitation of renal function with glomerular and tubular agents. Semin Nucl Med 1982; 12: 308–29.
   PubMed Web of Science ®Google Scholar
• Rehling M, Rabol A. Measurement of glomerular filtration rate in adults: accuracy of five single-sample plasma clearance methods. Clin Physiol 1989; 9: 171–82.
   PubMedGoogle Scholar
• Tian S, Kusano E, Ohara T, Tabei K, Itoh Y, Kawai T, et al. Cystatin C measurement and its practical use in patients with various renal diseases. Clin Nephrol 1997; 48: 104–8.
   PubMed Web of Science ®Google Scholar
• Erlandsen EJ, Randers E, Kristensen JH. Refer-ence intervals for serum cystatin C and serum crea-tinine in adults. Clin Chem Lab Med 1998; 36: 393–7.
   Google Scholar
• Norlund L, Fex G, Lanke J, von Schenck H, Nilsson J.-E, Leksell H, et al. Reference intervals for the glomerular filtration rate and cell-prolifera-tion markers: serum cystatin C and serum 132-microglobulin/cystatin C-ratio. Scand J Clin Lab Invest 1997; 57: 463–70.
   Google Scholar
• Bjarnadottir M, Grubb A, Olafsson I. Promoter-mediated, dexamethasone-induced increase in cystatin C production by Hela cells. Scand J Clin Lab Invest 1995; 55: 617–23.
   PubMed Web of Science ®Google Scholar